Ipilimumab: a human CTLA-4-blocking antibody Nivolumab: PD-1 binding immune checkpoint inhibitor Trabectedin: a marine-derived alkaloid;                       destroys cancer cells and                       destroys growth promoting M2 macrophages                       in the tumor microenvironment. Here, PDCD1 is linked to neoplasm.